Bausch Health (TSX:BHC) Short Interest


TSX:BHC Bausch Health Companies Inc TSX:BHC
64 GF Score
Price C$7.10
GF Value C$11.06
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TSX:BHC vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch Health Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Short Interest distribution charts can be found below:

* The bar in red indicates where Bausch Health's Short Interest falls into.


TSX:BHC
64GF Score
Bausch Health Companies Inc TSX:BHC
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bausch Health (TSX:BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of C$7.10 is trading 35.8% below its estimated GF Value™ of C$11.06. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for TSX:BHC:

  • Short Interest:
  • GF Value™: C$11.06 vs. price of C$7.10 (35.8% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the TSX:BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
64GF Score

Get the complete analysis for TSX:BHC

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$7.10
Price
C$11.06
GF Value